BTAX — Biostax Cashflow Statement
0.000.00%
Last trade - 00:00- $0.01m
- $1.50m
Annual cashflow statement for Biostax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.4 | 1.59 | 3.59 | -3.54 | -1.65 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.426 | -2.79 | -4.5 | 2.25 | 0.3 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.97 | 1.01 | 0.683 | 0.702 | 0.64 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.001 | -0.192 | -0.232 | -0.582 | -0.657 |
| Other Investing Cash Flow Items | 0 | — | — | -0.5 | 0 |
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | — | — | -0.5 | 0 |
| Financing Cash Flow Items | 0 | — | 0.716 | 0.006 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0.197 | 0.716 | 0.738 | 0.536 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.001 | 0.005 | 0.484 | -0.343 | -0.121 |